Trinity Health Foundation of East Tennessee Announces Leadership Transition H. Lee Martin, Ph.D., Retires Lynn Metler Named New President and Executive Director

TRIB Stock  USD 1.12  0.01  0.88%   
About 62% of Trinity Biotech's investor base is looking to short. The analysis of overall sentiment of trading Trinity Biotech plc stock suggests that many investors are alarmed at this time. The current market sentiment, together with Trinity Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Trinity Biotech plc stock news signals to limit their universe of possible portfolio assets.
  
PRNewswire -- The Board of Directors of Trinity Health Foundation of East Tennessee announced today a significant leadership transition. After 13 years of...

Read at prnewswire.com
prnewswire News
  

Trinity Biotech Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Trinity Biotech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Trinity Biotech Fundamental Analysis

We analyze Trinity Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trinity Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trinity Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Equity

Return On Equity Comparative Analysis

Trinity Biotech is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Trinity Biotech plc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Trinity Biotech stock to make a market-neutral strategy. Peer analysis of Trinity Biotech could also be used in its relative valuation, which is a method of valuing Trinity Biotech by comparing valuation metrics with similar companies.

Peers

Trinity Biotech Related Equities

NOTVInotiv   10.97   
0%
100.0%
ACRSAclaris Therapeutics   5.23   
0%
47.0%
NDRAENDRA Life   3.60   
0%
32.0%
SERASera Prognostics   2.80   
0%
25.0%
SHCSotera Health   1.16   
0%
10.0%
LABStandard Biotools   1.10   
0%
10.0%
STIMNeuronetics   1.05   
0%
9.0%
FONRFonar   0.36   
3.0%
0%
CSTLCastle Biosciences   0.43   
3.0%
0%
MDXHMDxHealth   0.51   
4.0%
0%
BDSXBiodesix   0.69   
6.0%
0%
PREPrenetics Global   1.56   
14.0%
0%
STRRPStar Equity   1.77   
16.0%
0%
XGNExagen   2.54   
23.0%
0%

Complementary Tools for Trinity Stock analysis

When running Trinity Biotech's price analysis, check to measure Trinity Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Biotech is operating at the current time. Most of Trinity Biotech's value examination focuses on studying past and present price action to predict the probability of Trinity Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trinity Biotech's price. Additionally, you may evaluate how the addition of Trinity Biotech to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stocks Directory
Find actively traded stocks across global markets